Browsing Tag
Jeremy Steele
1 post
Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Control Bionics has completed United States Food and Drug Administration establishment registration and device listing for NeuroStrip, strengthening its access to the company’s largest market while shifting investor attention toward paid adoption, subscription revenue and commercial scale.